SPIE收购nimeg并加强其在瑞士的生命科学业务-动脉网

SPIE Acquires nimeg and Strengthens Its Life Sciences Business in Switzerland

D-Pharm 等信源发布 2026-07-03 11:47



可切换为仅中文







SPIE announces the acquisition of nimeg ag, a specialized engineering service provider for the life sciences industry. With this acquisition, SPIE is strengthening its position in the growing market for pharmaceutical and

SPIE宣布收购nimeg ag，这是一家专注于生命科学行业的工程服务提供商。通过此次收购，SPIE正在加强其在不断增长的制药和

biotechnology

生物技术

facilities and expanding its range of industrial services in Switzerland.

设施，并在瑞士扩大其工业服务范围。

SPIE Acquires nimeg ag

SPIE 收购 nimeg ag

SPIE

国际光学工程学会

nimeg ag, headquartered in Baden-Dättwil in the canton of Aargau, specializes in engineering, planning, and project management services in the GMP environment for EPCMV projects (Engineering, Procurement, Construction Management, and Validation). The medium-sized company offers its first-class client base in the life sciences industry (pharmaceuticals, chemicals, biotech, medical technology) comprehensive engineering expertise in the planning and management of complex GMP projects.

nimeg ag 总部位于阿劳州的巴登-达特维尔，专注于为 EPCMV 项目（工程、采购、施工管理和验证）在 GMP 环境中提供工程、规划和项目管理服务。这家中型企业为生命科学行业（制药、化工、生物技术、医疗技术）的一流客户群提供复杂 GMP 项目规划与管理方面的全面工程专业知识。

In 2025, nimeg ag generated revenue of approximately 5 million euros..

2025年，nimeg ag 创造了约500万欧元的收入。

“We are confident that, as part of SPIE, we will be able to deliver even larger and more technically challenging projects for our clients in the future. By combining our strengths, we can execute comprehensive EPCMV projects as a general planner in the Swiss market. We look forward to our shared future and are confident that, with SPIE’s expertise and market position, we have found an excellent environment for our clients and our employees,” says Jan Paul-Hengstler, Managing Director of nimeg..

“我们坚信，作为SPIE的一部分，未来我们将能够为客户交付规模更大、技术挑战性更强的项目。通过整合双方优势，我们可以以总规划方的身份在瑞士市场执行全面的EPCMV项目。我们期待共同的未来，并深信凭借SPIE的专业专长和市场地位，我们已为客户和员工找到了一个卓越的发展环境。”nimeg公司总经理Jan Paul-Hengstler表示。

“We are very pleased to strengthen our life sciences expertise in Switzerland with nimeg’s engineering capabilities. By combining our capabilities, we will be able to offer EPC (Engineering, Procurement, and Construction) projects as a general contractor in the Swiss market and, together, provide customers with seamless, one-stop implementation.

“我们非常高兴能够通过 nimeg 的工程能力，加强我们在瑞士的生命科学领域专业实力。通过整合双方的能力，我们将能够以总承包商的身份在瑞士市场提供 EPC（设计、采购和施工）项目，并共同为客户提供无缝的一站式实施服务。”

We are very much looking forward to a successful future together!” says Alf Kain, Managing Director of SPIE Life Science Engineering..

“我们非常期待未来合作成功！”SPIE Life Science Engineering 董事总经理 Alf Kain 表示。

“We are very much looking forward to strengthening our presence in the life sciences sector with nimeg! Since the acquisition of Robur, we have been consistently expanding our expertise in industrial services and have significantly strengthened our range of services through the acquisitions of SPIE Life Science Engineering (formerly Otto Life Science Engineering), ROFA, and SGS Industrial Services,” says Dennis Mausberg, Head of the Industry Services & Wind Division and member of the Executive Board of SPIE Germany Switzerland Austria, outlining the growth trajectory of the industrial services division..

“我们非常期待通过与nimeg合作，加强我们在生命科学领域的布局！自收购Robur以来，我们持续拓展在工业服务领域的专业能力，并通过收购SPIE Life Science Engineering（前身为Otto Life Science Engineering）、ROFA以及SGS Industrial Services，显著增强了我们的服务范围。”SPIE德国瑞士奥地利公司工业服务与风电部门主管兼执行董事会成员Dennis Mausberg表示，他同时阐述了工业服务部门的增长轨迹。

“We are delighted to welcome nimeg to SPIE and to further deepen our industrial services expertise in the fast-growing life sciences sector. We are very much looking forward to our shared future and warmly welcome the team to SPIE,” says Rainer Hollang, Managing Director/CEO of SPIE Germany Switzerland Austria..

“我们很高兴欢迎 nimeg 加入 SPIE，并进一步深化我们在快速增长的生命科学领域的工业服务专业能力。我们非常期待我们的共同未来，并热烈欢迎 nimeg 团队加入 SPIE。”SPIE 德国、瑞士和奥地利地区董事总经理/首席执行官 Rainer Hollang 表示。

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of current news. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar.

注意：本文由计算机系统自动翻译，未经人工干预。LUMITOS 提供这些自动翻译，旨在呈现更广泛的最新新闻。由于本文采用自动翻译，可能存在词汇、句法或语法错误。

The original article in German can be found .

德文原文可在此处找到。

here

这里

。

https://www.bionity.com/en/news/1189116/spie-acquires-nimeg-and-strengthens-its-life-sciences-business-in-switzerland.html

Roche acquires Poseida Therapeutics

罗氏收购Poseida Therapeutics

Including cell therapy candidates and related platform technologies

包括细胞治疗候选药物及相关平台技术

Read news